Frank David 2/2/20 Frank David 2/2/20

A biotech VC’s prescription for what ails pharma

How can we balance innovation and affordability in prescription drugs? Peter Kolchinsky has some ideas.

Frank David 1/28/18 Frank David 1/28/18

How to prevent drug price shenanigans

Drug price scandals aren’t all the same - but here’s one that may be preventable.

Frank David 9/9/16 Frank David 9/9/16

Brent Saunders of Allergan shows pharma how it's done.

Frank David 8/31/16 Frank David 8/31/16

A timely test case for the math behind "value-based pricing".

Frank David 8/29/16 Frank David 8/29/16

Pharma needs to boost its credibility on drug pricing. How about renouncing huge yearly price hikes?

Frank David 8/29/16 Frank David 8/29/16

Pharma CEOs have the chance to take the "high ground" on drug pricing in the Turing brouhaha. I'm not holding my breath.

Frank David 1/1/15 Frank David 1/1/15

Is the new contracting deal in hepatitis C a meaningless blip, or the “end of days” for biopharma? (Spoiler alert: "no” and “no”.)

Frank David 12/5/14 Frank David 12/5/14

Think you can charge a lot more than generics when your drug is only a little bit better? Think again.

Frank David 8/12/14 Frank David 8/12/14

Pharma commercial teams are doing business like it's 2004 ... or maybe even 1994. It's time for a reboot.